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Transcription of the mouse mammary tumor virus DNA is known to be induced by several steroid hormones.
Using chimeric MMTV plasmids containing mutations within the hormone regulatory element, we have
previously studied the regions required for the glucocorticoid response in mouse fibroblasts. Here we report the
characterization of elements essential for the stimulation by progestins and androgens as compared with
glucocorticoids. The same set of mutant plasmids was transfected into the human mammary tumor cell line
T47D, and the specific transcripts were analyzed by an Si nuclease protection assay. Androgen-mediated
stimulation, although weak, showed an extended sensitivity to mutations, with a slight preference for the
proximal region. The results with progestin suggest that sequences within all the described sites protected by
the receptor in vitro are required and that the promoter-proximal region (-128 to -78 from the RNA start site)
is more important than the distal one (-190 to -160). Moreover, a binding site for nuclear factor I was not
required for the progestin response, whereas it was required for glucocorticoids. Thus, the various steroid
receptors play a role in the differential regulation of mouse mammary tumor virus transcription by recognizing
distinct sequence differences in the hormone regulatory element and interacting with different factors bound to
the promoter.
The mouse mammary tumor virus (MMTV) has been
successfully used as a model for studying the control of gene
expression by steroid hormones (reviewed in references 41
and 54). In particular, glucocorticoids have been shown to
stimulate MMTV transcription in infected cells (42, 55)
through the action of the glucocorticoid receptor. Mainly
because of the widespread occurrence of this receptor in
cultured cell lines, the DNA sequences required for gluco-
corticoid regulation have been investigated in more detail by
using cells transfected with chimeric DNA molecules (25, 28)
and have subsequently been mapped to the 200 base pairs
(bp) upstream of the MMTV RNA start site in the viral long
terminal repeat (LTR) (4, 26, 31). Using a series of mutant
plasmids containing clustered point mutations, small dele-
tions, or additions, we demonstrated that maximal stimula-
tion by glucocorticoids requires the cooperative action of
multiple, distinct sequence elements (5, 27). The strongest,
distal element maps at -181 to -172, inside an area that
binds the purified glucocorticoid receptor (39, 44). Further
elements map around -120, in one of the three proximal
receptor-binding sites (43), and in the symmetric sequence
around -70 recognized by nuclear factor I (NF-I [35, 38]).
MMTV primarily causes carcinomas of the mammary
gland, where proviral transcription mainly takes place (52).
The physiological effects of other hormones in this tissue
suggest that steroid hormones other than glucocorticoids
have a role in regulating MMTV in vivo (51). Progestins and
androgens, but not estrogens, have recently been reported to
stimulate transcription from MMTV LTR constructs intro-
duced into cell lines that express the respective receptors (8,
12). By using heterologous constructs, it has been shown (7)
that a DNA fragment from -236 to -52 conferred respon-
siveness to progestins and androgens on the thymidine
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kinase (tk) promoter, independently of orientation or dis-
tance and in a manner that was dependent on steroid-
receptor interactions. This hormone response element
(HRE) also provides glucocorticoid stimulation (40), and in
fact it contains overlapping in vitro binding sites for both
glucocorticoid and progesterone receptors (53). No data
regarding androgen receptor binding are as yet available.
In this report we analyze the contribution of specific areas
of the HRE to transcriptional regulation by progestins and
androgens, as well as glucocorticoids, in responsive mam-
mary cells transfected with a number of the mutants de-
scribed previously (5, 27). The results provide evidence that
in the natural context of the MMTV promoter, the proximal
upstream region is more important than the distal one for the
progestin and possibly the androgen responses and that the
NF-I binding site is not required for the progestin response,
in contrast to the situation observed with glucocorticoids. It
is suggested that subtle sequence and/or spacing variations
can be recognized by individual steroid receptors (possibly
in conjunction with other factors) to achieve differential
regulation of transcription.
MATERIALS AND METHODS
Plasmid constructions. The chimeric MMTV LTR-tk plas-
mids in which the HindIII linker 5'-CAAGCTTG-3' was
inserted at various positions in the HRE have been described
previously (27). Such mutants were named according to the
position of the LTR nucleotides immediately flanking the
linker. The mutants 151/145 ins and 201/192 ins were con-
structed by inserting a 123-bp HindIII fragment of mouse
DNA (27) into the respective linker mutants.
Cell culture and transfection. T47D cells were grown in
Dulbecco modified Eagle medium supplemented with 10%
fetal calf serum, bovine insulin (0.6 ,ug/ml), and antibiotics.
Subconfluent cells were transfected transiently by the
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DEAE-dextran method essentially as described previously
(8), except that the treatment with chloroquine diphosphate
was reduced to 1 h, the dimethyl sulfoxide shock was
omitted, and 1 pLg of plasmid pH514 was cotransfected with
10 ,ug of the MMTV plasmid per 10-cm petri dish. pH514
contains the rabbit 3-globin gene (33) and the simian virus 40
enhancer sequences (1) in a pAT153 vector. After 16 h,
hormones were added in fresh medium, and the cells were
incubated for a further 40 h before being harvested. Stable
transfections were performed by two different methods:
calcium phosphate precipitation (18) and electroporation
(37). For the calcium procedure, either supercoiled or
EcoRI-linearized MMTV test plasmids (6 to 8 ,ug) were
coprecipitated with 1.2 p.g of the plasmid pSV2neo (47) and
8 ,ug of carrier herring sperm DNA onto a 6-cm petri dish of
subconfluent T47D cells. In one series of transfections, 2.5
or 5 ,ug of an expression plasmid for the human glucocorti-
coid receptor gene (pRSV-hGRa [16]) was included in the
mixture of precipitated DNA. After 15 h, 0.1 mM chloro-
quine diphosphate (30) was added to the medium for 2 h, and
a glycerol shock (20% glycerol in medium, 2 min at room
temperature) was applied. After several washes, normal
medium was added for 2.5 days, and then the selection was
started, with 300 jLg of G418 sulfate (GIBCO Laboratories,
Grand Island, N.Y.) per ml. Most cells had detached after 10
days, and resistant clones were visible after another 1 to 2
weeks. Individual clones or pools of clones were expanded
for RNA and DNA analysis. Electroporation was performed
with an electronic cell-processing centrifuge coupled to a
high-voltage processor (D. E. P. Systems, Inc., Troy,
Mich.). Cells in suspension (105) were spun through 0.35 M
sucrose onto the electrode plate overlaid with 10 ,ug ofDNA
solution in 0.4 M sucrose. Two pulses of 800 to 1,000 V,
lasting 30 ,us each, were applied: the first after 1 min at 300
x g and the second after 10 s during which the speed was
increased to approximately 1,200 x g. The DNA solution
contained 5 ,ug of linearized MMTV plasmid and 1.5 ,ug of a
linearized plasmid containing the hygromycin B resistance
gene (2) under the control of the simian virus 40 promoter.
After the treatment, the cells were seeded in 6-cm petri
dishes. The medium was changed the next day, and selection
was started 2 days later with 25 ,ug of hygromycin B
(Boehringer GmbH, Mannheim, Federal Republic of Ger-
many) per ml. Up to 10 clones per plate were visible under
the phase-contrast microscope after about 2 weeks. They
were later pooled and expanded for nucleic acid extraction.
At 20 to 40 h prior to RNA isolation, the cultures received
fresh medium plus 10-' volume of ethanol with or without
hormones. The concentrations used were 10-8 M R5020 (17,
21-dimethyl-19-nor-4,9-pregnadiene-3,20-dione, a synthetic
progestin [Du Pont, NEN Research Products, Boston,
Mass.]), i0-' M dihydrotestosterone, and 10-6 M dexameth-
asone (a synthetic glucocorticoid) (both from Sigma Chem-
ical Co., St. Louis, Mo.). In stable transfectants, the pres-
ence of integrated plasmid DNA was assayed by Southern
blotting (46) with an LTR-specific probe. Digestion with the
enzyme BamHI revealed the intactness of the LTR, and
digestion with EcoRI (which cuts once in the plasmid) gave
an estimate of the arrangement and number of integrated
plasmids. Electroporation led mainly to the integration of
single DNA molecules, with one exception (the pool 189/180
[see Fig. 3]). The calcium precipitation method gave rise to
both single- and multiple-copy transfectants (data not
shown).
Nucleic acid analysis. DNA and total cytoplasmic RNA
were isolated from stably transfected cells by Nonidet P-40
lysis as described previously (4). RNA from transiently
transfected cells was prepared as described previously (32).
DNA (46) and RNA blot analyses were performed as de-
scribed previously (3). For determinations of actin mRNA
content, slot blots with 2 or 5 ,ug of total transfected-cell
RNA were hybridized for 20 h at 60°C with a random primer
radioactively labeled (14) PstI fragment of mouse ,-actin
cDNA (36) in 4x SSC (1x SSC is 0.15 M NaCl plus 0.015 M
sodium citrate) and washed in 0.1x SSC at 50°C. Similar
RNA dot blots were hybridized to a DNA probe representing
the 0.45-kbp BglII fragment in the N-terminal half of the
human glucocorticoid receptor (23) and gave a positive
signal in untransfected T47D cells (data not shown). S1
nuclease protection assays were carried out with 50 ,ug of
RNA and 5'-32P-labeled DNA probes: for MMTV, an LTR
fragment spanning the nucleotides from -204 to +134; for
P-globin, BamHI-digested plasmid H514 (27); and for the
glucocorticoid receptor, a 6-kbp BglII fragment of the plas-
mid pRSV-hGRa (16). Protected fragments were separated
on denaturing 6% polyacrylamide gels (34). Bands were
visualized by autoradiography at -70°C with X-Omat AR
films (Eastman Kodak Co., Rochester, N.Y.) and intensify-
ing screens, and their intensities were quantified by densi-
tometry after various exposure times.
DNase I footprinting. Cells were lysed by nonionic deter-
gents, and nuclear extracts were prepared by extraction with
100 mM salt and ammonium sulfate precipitation by the
method of Siebenlist et al. (45) for Ltk- cells and by the
method of Gorski et al. (17) for T47D cells. DNase I
protection experiments (15) were performed by the method
of Lichtsteiner et al. (29), using as a probe the 445-bp
StyI-BamHI fragment of the MMTV LTR from -306 to the
3' end of the LTR (3 _32P end labeled in the coding strand at
the BamHI site of the linker at +139 with [a-32P]dGTP and
Klenow DNA polymerase). The probe was incubated at 0°C
for 15 min with or without nuclear extracts, in the presence
of 50 jig of poly(dI:dC) per ml. After limited DNase diges-
tion, the deproteinized DNA was analyzed on a denaturing
5% polyacrylamide gel, along with the product of a sequenc-
ing reaction of the probe (34).
RESULTS
The plasmids used in this study consist of an MMTV LTR
linked to the coding sequence of the tk gene of herpes
FIG. 1. (A) Diagram of the HRE of the MMTV LTR-tk plasmid upstream of the RNA start site (+ 1) and sequences of relevant areas (13).
Symbols: 111111 , DNA segments protected in vitro against DNase I by the glucocorticoid receptor (44); 1 , limits of exonuclease III footprints
of the glucocorticoid (G) or progesterone (P) receptors (53): - (centered at position -70), dyad-symmetrical sequence that binds NF-I in
vitro (38). Symbols for previously defined transcriptional control elements for glucocorticoid hormones: _, distal and proximal elements;
EO , NF-I element; LII, TATA homology (5). (B) Structure of the mutant 129/88 DBS+ (27). Hindlll linkers are present at both sides of the
insert, which has the sequence of the distal receptor-binding site (DBS). (C) Structure of the mutant 151/145 ins spacer. A 123-bp HindIll
fragment of mouse DNA (27) was inserted in the mutant 151/145. The mutant 201/192 ins spacer contains the same spacer in the same
orientation inserted into the HindIll site between -201 and - 192. (D) Sequence of the LTR segments containing the mutations (sense strand).
The HindlIl linker in the mutants is underlined. (In the mutant 140/132, the last G of the linker was deleted in the cloning.) In the reference
wild-type sequence, a double line denotes the DNase I footprints of progesterone receptor on the sense strand (11).
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FIG. 2. Si nuclease protection assay of RNA from T47D cells transiently transfected with MMTV plasmids (as indicated above each lane)
plus the control plasmid H514 carrying the rabbit P-globin gene and treated with R5020. MMTV mRNA protects a fragment of 142 nucleotides,
and ,B-globin mRNA protects one of 212 nucleotides. (A) Lanes: 1, wild type; 2 to 15, mutants; M, 3'-32P-labeled molecular size markers
(Hinfl-digested pBR322) (their sizes in nucleotides are given on the left). (B) Comparison of mutants with a 123-bp spacer insertion and the
corresponding linker-scanning mutants.
simplex virus and cloned into pBR322 (Fig. 1A). The mu-
tants contain an 8-bp HindIlI linker replacing the natural
sequence at various locations in the HRE (Fig. 1D). The
substitutions leave the neighboring DNA either perfectly
aligned or slightly shifted (by 1 to 3 nucleotides), whereas
other mutations consist of deletions or insertions of DNA
fragments (Fig. 1B and C). Details of the construction of
these plasmids, and their functional analysis with respect to
the response to glucocorticoid hormones in mouse Ltk-
fibroblasts, have been presented previously (5, 27). The
constructs were transfected stably or transiently into the
human mammary tumor cell line T47D, reported to have
retained high levels of the progestin receptor and moderate
levels of the androgen receptor but low levels of the gluco-
corticoid receptor (10, 24). The T47D cells used in our
experiments did not respond to dexamethasone when trans-
fected with the wild-type MMTV LTR plasmid (data not
shown), whereas they did respond when cotransfected with
a plasmid expressing the complete cDNA for the human
glucocorticoid receptor (see Fig. 3b, lane 4). The ability of
the mutants to be transcriptionally stimulated by steroid
hormones was analyzed in nuclease SI protection experi-
ments with cytoplasmic RNA of transfected cells. In the
transient-transfection assays, transcription from a cotrans-
fected plasmid containing the rabbit B-globin gene with its
own promoter and the simian virus 40 enhancer (1) provided
an internal standard unaffected by hormones. In stable
transfections, the mRNA content of cytoplasmic RNA prep-
arations was standardized by hybridization to a ,B-actin
probe and did not vary upon hormone treatment. Typical
autoradiographs obtained with either transient- or stable-
transfection assays are shown in Fig. 2 and 3, respectively.
Quantitative data were obtained from densitometry of auto-
radiographs at different exposure times and are summarized
in Table 1.
Induction factors for progestin and androgen were derived
from stable transfections with the wild-type plasmid. For the
progesterone analog R5020 (10-8 M) the induction factor
was about 60-fold, whereas with dihydrotestosterone (10-7
M) there was a 7-fold stimulation above the basal level
(Table 1). In cells cotransfected with the glucocorticoid
receptor gene, the induction by dexamethasone was approx-
imately 200-fold. Transcription without hormone was unde-
tectable in transiently transfected cells, and relative stimu-
lation factors were derived by comparing the levels of RNA
transcribed from mutant and wild-type plasmids.
The distal element plays a minor role in progestin stimula-
tion of the promoter. T47D cells transfected with plasmids
carrying a deletion between -193 and -78 upstream of the
cap site did not show any detectable stimulation of transcrip-
tion in response to progestin addition (Fig. 2A, lane 2).
Hence, the deleted DNA fragment, which contains the four
in vitro binding sites for the purified progesterone receptor
(53) (Fig. 1A), also contains the functional element(s) re-
quired for progestin stimulation of the MMTV promoter.
The use of linker-scanning mutants within this region of the
LTR allowed us to define in more detail the specific se-
quences involved. The results of transfection experiments
with plasmids mutated in the area between -200 and -160,
which covers the most distal of the in vitro receptor-binding
sites, led to the conclusion that this region is less important
for the progestin-mediated response than more proximal
ones are (Table 1). Deletion of the complete distal receptor-
binding site (mutant 193/162) caused a ca. twofold reduction
in the progestin response (Fig. 2A, lane 3; Table 1). A
comparable reduction was seen, both in stable and in tran-
sient transfections, with mutants 176/169 (Fig. 3a, lanes 14
and 15) and 176/166 (Fig. 2A, lane 6), which have lost the
consensus hexanucleotide TGTTCT common to all four
binding sites for the progesterone receptor (Fig. 1A). In the
transient-expression assay, mutations upstream (to -196) or
downstream (to -132) gave R5020 stimulation levels com-
parable to those in the wild type (some values higher than
100% are not considered different from wild-type values)
I
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FIG. 3. S1 nuclease protection assays of RNA from T47D cells stably transfected with wild-type (wt) or mutant MMTV plasmids, as
indicated above the panels. In panel (b), transfectants also containing the human glucocorticoid receptor gene in an expression vector
(pRSV-hGRa [16]) were analyzed for the dexamethasone response. Cultures were treated with ethanol (lanes C), R5020 (lanes R),
dihydrotestosterone (lanes T), or dexamethasone (lanes D). Correctly initiated mRNA protects a fragment of 142 nucleotides (nt) from Si
digestion. In lanes 4 to 7, the hormone treatments were performed in separate experiments, and the relative control lane (C) is shown to the
left of each experimental lane. RNA from isolated clones was used in lanes 16 to 18 and 25 to 27 of panel (a) and lanes 21 to 24 of panel (b).
The other lanes contain RNA from pools of clones.
(Fig. 2A, lanes 4, 5, and 7; Table 1). With stably transfected
cells, for which the ratio between stimulated and basal levels
was determined, we observed a two- to threefold reduction
with different mutants covering the whole distal region from
-190 to -162 (or possibly -145 [Table 1]). The discrepancy
with respect to the data from transient-expression assays, in
which absolute stimulated levels are considered, may be
explained by differences in the basal levels of transcription
(Fig. 3a, lanes 1 to 18).
The proximal element is particularly important for the
progestin-mediated response. The DNA segment from -125
to -70 contains three promoter-proximal binding sites for
the purified progesterone receptor in vitro (53) (Fig. 1A).
Mutations of sequences within this area have a more dra-
matic effect on the progestin-induced transcription level than
do mutations in the distal site. Deletion of two of the three
proximal binding sites, as in the mutant 129/88, reduced the
amount of progestin-stimulated RNA fourfold or more (Fig.
2A, lane 14; Fig. 3a, lanes 19 and 20; Table 1). No increase
in the number of transcripts was observed when an oligonu-
cleotide harboring the sequence of the distal receptor-
binding site (-192 to -165) was inserted into this mutant via
the HindlIl linker (129/88 DBS+; Fig. 1B). In fact, in
transient transfections this construct gave an even lower
level of transcription (Fig. 2A, lane 14 versus lane 15; Table
1). The mutants 125/116 and 115/105 directly affect the most
upstream of the three proximal binding sites. Both displayed
a reduced progestin response (Fig. 2A, lanes 8 and 9; Fig. 3a,
lanes 22 and 23; Table 1). The deletion mutant 101/78 lacks
the middle binding site and the 5' boundary of the most
proximal one. This mutant showed a stimulation of only 10%
of wild-type levels, the lowest detectable signal in the
transient-transfection assays (Fig. 2A, lane 10; Table 1), and
the induced levels were extremely low in stable transfectants
(data not shown). The plasmid 96/88, in which the mutation
affects the middle binding site but leaves all but the last base
pair of the consensus hexanucleotide intact, showed a three-
fold-reduced progestin response (Fig. 2A, lane 11; Fig. 3a,
wt
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TABLE 1. Quantification of the effect of mutations in the LTR
on transcriptional regulation by progestin (R5020)
or androgen (DHT)
R 5020" DHTb
Stabletransfction Transient (stable
Plasmid" Stable transfection transfection transfection)
No. Fold % of % of No. Fold
analyzed stimu- w. t. w.t. analyzed stimulation lation
w.t. iP 60x 100 100 iP 7x
196/186 101
190/181 2P 28x 47 135 1P 6x
189/180 iP 31x 52 80 iP 6x
186/177 2P 30x 50 96 iP 2.5x
181/175 132
176/169 iP 35x 58
176/166 67
D193/162 iC 24x 40 54 iC 2.7x
161/145 131
151/145 3C 32x 53 90 2C 2.3x
151/145 SP 1P,2C 4x 7 1P,2C lx
140/132 150
D129/88 iP 2x 3 28 iP lx
D129/88DBS + 15
125/116 iP <lOx <17 40
115/105 30
D101/78 10
96/88 1P,2C 20x 33 33 iC 3x
90/78 iP 8x 13 26 1P,1C 1.4x
90/70 3P,1C 34x 57 37
D193/78 <5
" T47D cells were transfected with the MMTV LTR/TK wild-type plasmid
(w.t.) or its linker-scanning, deletion (D), or insertion derivatives. SP denotes
insertion of the 123-bp spacer (Fig. 1C). DBS+ denotes insertion of a distal
binding site in the correct orientation (Fig. 1B).
b The quantitation is based on densitometric scanning of the 142-nucleotide
band of different autoradiographic exposures of Si mapping experiments. For
transient-transfection assays, the data were normalized to the p-globin
internal standard and are based on three or more determinations. For
stable-transfection assays, they were normalized to the content of cellular
l-actin mRNA, and the number of pools (P) or isolated clones (C) analyzed is
given.
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FIG. 4. DNase I footprint analysis of NF-I from T47D and Ltk-
cells on MMTV DNA. Two concentrations of nuclear extracts from
Ltk- cells (lanes 6 and 7) or T47D cells (lanes 8 and 9) were
incubated with the probe DNA, labeled in the coding strand at the 3'
end of the LTR, and digested with DNase I. Lanes 4 and 5 show the
pattern of free DNA incubated in the absence of nuclear extract.
Lane 3 shows a G+A sequencing ladder of the probe; lanes 1 and 2
contain molecular size markers as indicated on the left.
lanes 25 and 26; Table 1). The mutant 90/78, which lacks half
of the most proximal binding site including the 6-bp consen-
sus sequence, produced a low progestin response in both
stable and transient transfections (Fig. 2A, lane 12; Fig. 3a,
lanes 28 and 29; Table 1).
Centered at nucleotide -70 is a sequence with an imper-
fect dyad symmetry that was shown to bind in vitro the
ubiquitous nuclear protein termed TGGCA-binding protein,
or NF-I (38). The mutant 90/70, with a net deletion of 11 bp,
has lost the 5' half of the dyad symmetry along with the most
proximal binding site for the progestin receptor. In transient-
transfection assays it showed a slightly higher response than
did the overlapping mutant 90/78, in which the NF-I binding
site is intact (Fig. 2A, lane 13; Table 1). In stably transfected
cells (Fig. 3a, lanes 31 and 32; Fig. 3b, lanes 21 and 22) the
progestin stimulation was significantly higher in mutant 90/70
than in mutant 90/78 (Table 1) in terms of the ratio between
induced and control RNA levels. The apparent discrepancy
may be eliminated if it is considered that the mutation in the
NF-I site caused a reduction of approximately fourfold in the
basal level of promoter activity in mouse Ltk- cells (6). In
T47D cells transfected with the 90/70 plasmid, the unstimu-
lated level of transcription was indeed undetectable in two
pools and one clone, despite a relatively high induced level
of RNA, and this might lead to a higher stimulation factor.
DNase I in vitro footprinting analysis with nuclear extracts
from T47D and Ltk- cells showed protection of the same
sequences on wild-type MMTV DNA, between -80 and -58
from the cap site (Fig. 4), corresponding to the NF-I binding
site (38). No DNase I protection in this area was observed on
DNA of the 90/70 mutant (6). In the region closer to the
promoter, the mutant 37/11 (which removes the TATA
homology) gave extremely low levels of correctly initiated
transcripts, even in the presence of progestin. They were
accompanied by faint bands derived from transcripts with
heterogeneous 5' ends (data not shown). Finally, we tested
the effect of disrupting the spatial arrangement of the distal
versus the proximal regulatory domains on the ability of
such mutants to respond to progestin. A relatively long DNA
fragment with an unrelated sequence (a 123-bp Hindlll
fragment of mouse DNA [27]) was inserted at positions -151
to -145 (Fig. 1C). This resulted in a drastic reduction in
R5020 stimulation (Fig. 2B, lane 3 versus lane 4; Table 1).
The same spacer did not affect the response when inserted
upstream of the distal element at position -192 (Fig. 2B,
lane 1 versus lane 2), indicating that it did not have a general
inhibitory effect on transcription. This suggests that the
MOL. CELL. BIOL.
STEROID INDUCTION OF MMTV 4005
spacing between the distal and the proximal progestin regu-
latory elements plays a role in the response to the hormone.
Sequences required for the androgen-mediated response.
Results for the androgen stimulation of the MMTV promoter
were derived from the analysis of stably transfected cells,
because of the higher sensitivity of the method. Still, the
relatively weak response prevented any firm conclusions,
and only a general pattern could be delineated. The data are
shown in Fig. 3 and compiled in Table 1. In T47D cells
transfected with the wild-type plasmid, the increase in the
level of specific transcripts obtained after addition of 10-7 M
dihydrotestosterone was only approximately sevenfold, or
about eightfold lower than for progestin stimulation. The
results obtained with the mutant plasmids showed that, as
for progestins, the sequences in the distal part of the HRE
were only moderately important for androgen stimulation.
Two plasmids with mutations between -190 and -180 were
still able to mediate an androgen response within the normal
range. A possible sensitive area is indicated by the mutant
176/169, which in a pool of transfectants was transcribed
40-fold less well after androgen addition than after progestin
addition (Fig. 3a, lanes 14 and 15), as opposed to 8-fold in the
wild type. This mutation affects the consensus hexanucle-
otide of glucocorticoid and progesterone receptor-binding
sites. The mutation 186/177, located immediately upstream
of the consensus sequence, caused a less than threefold
reduction in androgen stimulation (Fig. 3a, lanes 10 and 12;
Table 1), and, at least in the clone analyzed, a deletion that
covers the whole distal region between -193 and -162 had
a similar effect (Table 1). For the next 30 bp from -160 to
-130, only the mutation 151/145 was investigated, and in
three independent clones it displayed a positive, although
reduced, response to androgens. The insertion into this site
of an unrelated sequence of 123 bp (mutant 151/145 ins
spacer [27]) produced, as in the case of progestin, a strong
negative effect and completely obliterated the testosterone
response (Table 1), without affecting the base level of
transcription.
In the proximal region, deletion of the two upstream
consensus hexanucleotides (in plasmid 129/88 [Fig. 3a, lanes
19 and 21]) or mutation of the third one (in plasmid 90/78
[Fig. 3a, lanes 28 and 30]) abolished the androgen response
(Table 1). A threefold induction was still present in a clone of
cells containing about 15 copies of the plasmid 96/88 (Fig. 3a,
lanes 25 and 27; Table 1), whereas no signal with androgen
was observed in another clone or in a pool that showed
respectable amounts of progestin-induced RNA (data not
shown). Compared with progestin, the androgen response
was also extremely weak in transfectants with the 90/70
plasmid (Fig. 3a, lanes 32 and 33; Fig. 3b, lanes 22 and 23).
Glucocorticoid response in T47D cells cotransfected with the
gene for its receptor. To compare the relative contributions
of regulatory elements, we wanted to assess the extent of
transcriptional stimulation by the synthetic glucocorticoid
hormone dexamethasone in the same cells in which proges-
tin and androgen effects were observed. T47D cells, which
naturally do not respond to dexamethasone, were cotrans-
fected with a plasmid expressing the human glucocorticoid
receptor (pRSV-hGRa [16]) and some of the MMTV-tk
plasmids. The level of expression of the introduced receptor
gene in stably transfected cells was evaluated by quantitative
S1 nuclease protection assays in which RNA annealed to a
5'-end-labeled probe derived from the pRSV-hGRa plasmid
and spanning the cap site was used (data not shown). This
allowed the distinction between mRNA transcribed from the
transfected plasmid and that endogenous to the cells, pre-
sumably coding for a receptor which does not respond to
dexamethasone. In this assay, comparable levels of gluco-
corticoid receptor mRNA were detected in the transfectants
shown in Fig. 3b, with the exception of the pool 129/88,
which had about sixfold-higher levels. It is therefore unlikely
that differences in glucocorticoid stimulation were caused by
different amounts of receptor in the cells. The results of the
S1 mapping of MMTV-initiated RNA accumulated under
stimulation by dexamethasone, as well as progestin and
androgen, in such stable transfectants are shown in Fig. 3b.
The pool of transfectants containing the wild-type MMTV
LTR plasmid showed a much higher stimulation by dexa-
methasone than by the progestin R5020 (lane 4 versus lane
2). The inverse situation was found in cells harboring two
different mutants in the distal receptor-binding site, 186/177
and 176/169 (lane 8 versus lane 6 and lane 12 versus lane 10),
indicating a more drastic effect of the mutations on the
glucocorticoid response. In a pool of transfectants with a
deletion mutant lacking two of the three proximal receptor-
binding sites (129/88), the levels of MMTV-specific tran-
scripts were similar in the presence of dexamethasone and
R5020 (Fig. 3b, lane 16 versus lane 14). Since about sixfold
more glucocorticoid receptor was present in these cells than
in the wild-type transfectant, the result suggests a strong
reduction of the dexamethasone response. In the proximal-
binding-site mutant 90/78, the response to dexamethasone
was slightly higher than that to R5020 (Fig. 3b, lane 20 versus
lane 18), whereas it was strongly reduced in one pool and
one isolated clone (lane 24 versus lane 22) containing the
mutant in the NF-I binding site, 90/70.
DISCUSSION
The results presented here show that within the 200 bp
upstream of the RNA start site of the MMTV LTR, distinct
sequence elements are involved in the regulation of tran-
scription by progestins and androgens, as well as glucocor-
ticoids. Roughly, they can be located to a distal and a
proximal area, analogous to the glucocorticoid regulatory
elements defined previously by using mouse fibroblasts (5).
The purified progesterone and glucocorticoid receptors were
shown to cover the same sites on the MMTV DNA in
exonuclease III protection assays (53), but clear differences
in the details of the protein-DNA interactions, in particular
in the promoter-proximal binding site, have been reported
recently (11). Although the detailed functional analyses were
performed with different cell types and may not be directly
compared, a differential sensitivity to certain mutations in
the progestin versus glucocorticoid response was apparent
from a comparison of our present and previous (5, 27)
studies. The use of exogenous glucocorticoid receptor pro-
vided by transfection to the mammary cells corroborated the
notion that the distal regulatory element is more strongly
involved in the response to glucocorticoids than to prog-
estins and that an intact NF-I binding site is required for
glucocorticoid but not for progestin action. Only tentative
conclusions can be drawn for androgens, owing to the low
stimulation levels observed. The data indicate a diffuse
sensitivity to mutations, somewhat higher in the proximal
region.
A weak distal control element for progestins may be
defined by certain mutations in the area between -190 and
-160, but its boundaries cannot be precisely located (Table
1). The extent of impairment for the various mutants was
only two- to threefold, the strongest impact possibly being
associated with mutations in the hexanucleotide 5'-TGT
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TCT-3', which is conserved in all four receptor-binding sites.
For glucocorticoids, in contrast, the distal element gave the
most important contribution to the response: reductions of
10- to 20-fold with respect to the wild type were observed for
some of the mutants in Ltk- fibroblasts (5) and similarly in
T47D mammary cells cotransfected with the receptor gene
(Fig. 3b). The segment from -160 to -130 appears rather
insensitive to mutations. An indication that the distal recep-
tor-binding site is nonetheless required for progestin and
androgen is provided by the result of the insertion of a long
spacer between distal and proximal elements, which strongly
affected the progestin response and completely abolished the
effect of androgen. The same fragment located at position
-192 had no negative influence on transcription (Fig. 2B).
This suggests that the effect of the spacer is due to the
disruption of the relative arrangement of distal versus prox-
imal regulatory elements, rather than to the presence of
sequences contained in the inserted DNA. That physical
interactions between receptors can occur was shown in an
electron microscopy study (50) in which progesterone recep-
tors appeared associated in pairs on the MMTV HRE. Using
the same constructs, we observed a similar requirement for
spacing of the elements in the glucocorticoid response in
Ltk- cells (6).
The promoter-proximal region (roughly between - 128 and
-78) contains the major regulatory element(s) for progestins
and, possibly, androgens. Several plasmids with mutations
in this area showed a reduced response to both hormones
and were, on the whole, more strongly affected than plas-
mids with mutations in the distal region (Table 1). The
plasmid 125/116 is mutated at four positions between -121
and -117 in the conserved hexanucleotide, yet this sequence
and the two other TGTTCT motifs of the proximal region are
unaltered in plasmid 115/105, which also gave a reduced
progestin response. We conclude that a progestin regulatory
element extends farther than the consensus sequence and
possibly includes the whole in vitro footprint. The next two
mutants (96/88 and 90/78) also had reduced progestin and
androgen responses. The mutation in 96/88 affects the middle
receptor-binding site while leaving 5 of 6 bp of the consensus
sequence unaltered. The mutation in 90/78 largely removes
the most proximal binding site, and, in addition, the net loss
of 3 bp causes a distortion in the stereospecific alignment
between the upstream and the promoter regions. No such
distortion occurs in the mutant 90/70, with a net deletion of
11 bp, or about 1 turn of the DNA helix. The observation
that the mutant 90/70 is less severely affected than 90/78 may
suggest that such an alignment is required in the proximal
element for progestin regulation. A need for such steric
relationships for optimal functioning of DNA sequences
involved in interactions with proteins has been demonstrated
for the simian virus 40 promoter (49) and for repressors
bound at the cI gene promoter of bacteriophage lambda (21).
In two additional plasmids with mutations of the proximal
region, two receptor-binding sites are simultaneously de-
leted: in the plasmid 129/88 and in the plasmid 101/78, with a
net removal of 3 and 1.5 helix turns, respectively. Both gave
a very low progestin stimulation. The insertion between
-129 and -88 of a synthetic oligonucleotide with the se-
quence of the complete distal receptor-binding site did not
restore the progestin stimulation (Fig. 2A), although this had
been the case for the glucocorticoid response in Ltk- cells
(27). This result further strengthens the conclusion that the
distal element plays a lesser role in progestin stimulation
than it does for glucocorticoids. As for the proximal recep-
tor-binding site, our results show that it is more strongly
involved in the progestin (and possibly androgen) responses.
Concerning progestin regulation, a qualitatively similar con-
clusion can be drawn from two very recent studies on steroid
hormone inducibility of identical sets of linker-scanning
mutants transiently assayed in T47D cells (9, 11). In both
cases, the lowest progestin stimulation was observed with a
mutant altered in the proximal consensus hexanucleotide
between -121 and -114. However, a mutation between
-110 and -103 had much less effect, whereas in our study
the mutant 115/105 was also significantly reduced in the
progestin response. Since in both instances the consensus
sequence is preserved, more precisely defined base muta-
tions are needed to identify individual contributions of
residues in this area. In the study that used the natural
MMTV promoter (9), the smallest impact was of a mutation
in the distal consensus hexanucleotide, in agreement with
our observations. When comparing relative effects of the
same mutations on the progestin and the glucocorticoid
responses, the two reports disagree on the results for the
distal as well as two proximal element mutants. Since the
other study (11) used the HRE upstream of -70 linked to the
herpes simplex virus tk promoter, it remains to be seen
whether the divergence can be attributed to the absence of
the NF-I binding site or to the juxtaposition of heterologous
promoters and enhancer elements.
Concerning the androgen response, we observed a reduc-
tion in all mutants with mutations downstream of -180; the
effects of mutations or deletions appeared less pronounced
in the distal than in the proximal region, but the overall
stimulation was low, which made quantitation difficult. One
of the above-mentioned studies (9) analyzed androgen ef-
fects in T47D cells that gave a higher response; an extremely
strong reduction was found with all mutations tested, and a
similar pattern was found with a glucocorticoid hormone
other than dexamethasone that is recognized by the T47D
cell receptor. The discrepancy between this set of data and
ours may be explained by the different sequences used as
mutations (CCCGGG or CAAGCTTG). With respect to
glucocorticoids, the available data indicate that the relative
importance of the proximal region may vary quantitatively
depending on the cell type: the same plasmids (129/88 and
90/78) showed a stronger negative effect in T47D cells (Fig.
3b) than in Ltk- cells (5). Qualitatively, their relative impact
was similar, in that the mutant 129/88 gave a lower induction
than 90/78; however, the latter gave results close to those for
the wild type in Ltk- cells, although not in T47D cells (Fig.
3b). Cell-specific differences in the sensitivity to mutations in
the proximal element have also been observed by others (9,
11).
The comparison of the pair of mutants 90/78 and 90/70
reveals a clear difference in the requirement of progestins or
glucocorticoids for a functional NF-I binding site. The
mutant 90/70, compared with 90/78, lacks half of the NF-I
recognition sequence (38) and does not bind NF-I in a DNase
I in vitro footprinting analysis with nuclear extracts, whereas
90/78 does (6). T47D cells also contain an NF-I binding
activity (Fig. 4) that is required for the glucocorticoid
response, in agreement with previous observations with
Ltk- cells (5) and human MCF-7 cells (35). The fact that the
mutant 90/70 did not cause any further reduction in progestin
response than the mutant 90/78 implies that an intact NF-I
binding site is not required for progestin stimulation. A
similar conclusion has been reached by others using a
different mutant affecting NF-I binding (9). The glucocorti-
coid and progesterone receptors show extensive divergence
in the amino-terminal portion of the molecule (19), which, in
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the case of the glucocorticoid receptor, has a modulating
function (16, 22). One might speculate that the differential
requirements of these two different steroids for the NF-I
binding site reflect different interactions between NF-I (or
other transcription factors) and receptor proteins, possibly
involving their amino-terminal domains. The use of mutated
receptors for the activation of wild-type and mutated LTRs
may help elucidate the mechanisms of the postulated inter-
actions.
Two recent reports (20, 48) provided evidence that a 15-bp
oligonucleotide with partial dyad symmetry taken from a
glucocorticoid response element could act as a progestin-,
androgen-, or glucocorticoid-stimulated enhancer and that
point mutations in this sequence affected the response to the
hormones in a similar manner in different responsive cells.
This result may primarily reflect a high structural similarity
in the DNA-binding domains of the respective receptors, as
indicated by the high identity in amino acid sequence (re-
viewed in reference 19). In a steroid-induced gene, the actual
arrangement of regulatory elements often comprises more
than one receptor-binding site, in addition to sequences
interacting with transcription factors of other kinds. A more
subtle hormonal regulation may then be achieved by varia-
tions in the sequence context or in the distance and relative
orientation of bound receptors to each other or to the
factors. For these interactions, other portions of the receptor
molecule are likely to be required. The data presented here
support this notion of differential roles for each component
of a set of regulatory elements.
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